Skip to main content

Table 3 Clinical course and outcomes of critically ill pH1N1 patients, stratified by AKI

From: Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: cohort study

 

Overall

AKI

No AKI

P value

(n = 562)

(n = 342)

(n = 220)

Day 1 support, physiology, and laboratory values

APACHE II score (n = 508, 306, 202)

21.1 (9.2)

23.0 (9.6)

18.1 (7.6)

<0.0001

SOFA score (n = 361, 216, 145)

11.2 (3.8)

12.0 (3.8)

9.7 (3.2)

<0.0001

Invasive mechanical ventilation (n = 553, 338, 215)

384 (69.4)

241 (71.3)

143 (66.5)

0.23

Inotrope or vasopressor

251 (44.7)

164 (48.0)

87 (39.6)

0.05

Mean arterial pressure (mmHg) (n = 522, 315, 207)

74 (19)

73 (19)

76 (19)

0.14

Heart rate (beats/min) (n = 433, 262, 171)

104 (24)

106 (25)

102 (22)

0.07

Temperature (°C) (n = 405, 244, 161)

37.6 (1.2)

37.6 (1.3)

37.7 (1.2)

0.84

PaO2/FiO2 (n = 496, 299, 197)

153 (96)

143 (94)

167 (98)

0.006

CK (U/L) (n = 230, 137, 93)

293 (91-835)

320 (102-949)

206 (90-681)

0.08

CK > 5000 IU/L (n = 230, 137, 93)

13 (5.7)

10 (7.3)

3 (3.2)

0.19

WBC (109/L) (n = 409, 243, 166)

9.6 (6.5)

9.7 (6.8)

9.3 (6.0)

0.45

Albumin (g/L) (n = 275, 167, 108)

26.2 (7.0)

26.1 (7.1)

26.4 (7.0)

0.77

Platelets (109/L) (n = 520, 313, 207)

188 (96)

184 (95)

194 (96)

0.26

Urea (mmol/L) (n = 76, 44, 32)

10.5 (21.0)

14.4 (26.9)

5.1 (2.8)

0.03

Creatinine (μmol/L) (n = 537, 326, 211)

124 (120)

155 (144)

76 (31)

<0.0001

Urine output (mL/24 hr) (n = 431, 270, 161)

1439 (1055)

1070 (939)

2058 (946)

<0.0001

Clinical course and outcomes

Invasive mechanical ventilation

499 (88.8)

313 (91.5)

186 (84.6)

0.01

Inotropes or vasopressors

339 (60.3)

222 (64.9)

117 (53.2)

0.006

Antiviral treatment

530 (94.3)

326 (95.3)

204 (92.7)

0.20

Renal replacement therapy (n = 561, 342, 219)

85 (15.2)

85 (24.9)

0

<0.0001

Days of hospital stay (n = 523, 319, 204)

19.0 (12.0-35.0)

20.0 (12.0-40.0)

17.0 (12.0-30.0)

0.13

Days of ICU stay (n = 539, 325, 214)

11.0 (7.0-20.0)

12.0 (7.0-24.0)

10.0 (6.0-16.0)

0.002

Hospital mortality (n = 545, 329, 216)

113 (20.7)

85 (25.8)

28 (13.0)

0.0003

  1. AKI is defined by the RIFLE Injury or Failure categories and no AKI by the RIFLE None or Risk categories.
  2. Categorical data are presented as n (%) and continuous data as mean (SD) or median (Q1-Q3). For each variable, we specify (n) with data if it differs from the total in the first row.